Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcadia Biosciences, Inc. - Common Stock (NQ: RKDA )

6.350 +0.130 (+2.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Arcadia Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
Crude Oil Edges Lower; US Initial Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Arcadia Biosciences Stock Are On The Rise Today: What's Going On?
Shares of Arcadia Biosciences, Inc. (NASDAQ: RKDA) are trading higher Thursday following the company's announcement of an all-stock merger with Roosevelt Resources LP. Here's what you need to know. 
Via Benzinga
Dow Falls 50 Points; Kroger Posts Downbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 12, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning! 
Via InvestorPlace
Recap: Arcadia Biosciences Q4 Earnings
Via Benzinga
Earnings Outlook For Arcadia Biosciences
Via Benzinga
Arcadia Biosciences's Return On Capital Employed Insights
Via Benzinga
Earnings Preview For Arcadia Biosciences
Via Benzinga
RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024
RKDA stock results show that Arcadia Biosciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
RKDA Stock Earnings: Arcadia Biosciences Beats EPS, Beats Revenue for Q1 2024
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
RKDA Stock Earnings: Arcadia Biosciences Beats EPS, Misses Revenue for Q4 2023
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving Premarket
Gainers AgileThought, Inc. (NASDAQ: AGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday. 
Via Benzinga
Arcadia Biosciences Seeks Strategic Options; Warns On Challenging Economic Headwinds
Plant-based health and wellness products producer Arcadia Biosciences Inc (NASDAQ: RKDA) said it looks 
Via Benzinga
Top 5 Consumer Staples Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Gainers ObsEva SA (NASDAQ: OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in... 
Via Benzinga
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 99 companies made new 52-week lows. 
Via Benzinga
SPX, Nasdaq Eye 3-Straight Losses
Following a retreat in jobless claims, interest rates are at the forefront of investors' minds this afternoon. 
Via Talk Markets
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.